DE1670684A1
(de)
|
1966-04-01 |
1970-12-03 |
Hoechst Ag |
Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
|
WO1990012321A1
(en)
|
1989-03-31 |
1990-10-18 |
The Cancer Institute Board |
Halogenated dna ligand radiosensitisers for cancer therapy
|
US5667975A
(en)
|
1994-05-06 |
1997-09-16 |
The University Of North Carolina |
Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans
|
EP0777656B1
(en)
|
1994-08-26 |
2004-04-14 |
Auckland Division Cancer Society Of New Zealand (Incorporated) |
Novel dna-targeted alkylating agents
|
US5668166A
(en)
|
1995-06-07 |
1997-09-16 |
Georgia State University Research Foundation, Inc. |
Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor
|
US5643935A
(en)
|
1995-06-07 |
1997-07-01 |
The University Of North Carolina At Chapel Hill |
Method of combatting infectious diseases using dicationic bis-benzimidazoles
|
AUPN449295A0
(en)
|
1995-07-28 |
1995-08-24 |
Inner And Eastern Health Care Network, The |
Radioprotectors
|
US5770617A
(en)
|
1996-03-20 |
1998-06-23 |
Rutgers, The State University Of New Jersey |
Terbenzimidazoles useful as antifungal agents
|
EP0988037A1
(en)
|
1997-02-05 |
2000-03-29 |
Board Of Regents, The University Of Texas System |
Porphyrin compounds as telomerase inhibitors
|
US5935982A
(en)
|
1997-02-28 |
1999-08-10 |
The University Of North Carolina At Chapel Hill |
Methods of treating retroviral infection and compounds useful therefor
|
US6063801A
(en)
|
1998-02-12 |
2000-05-16 |
Rutgers, The State University Of New Jersey |
Heterocyclic topoisomerase poisons
|
TWI244481B
(en)
|
1998-12-23 |
2005-12-01 |
Pfizer |
3-azabicyclo[3.1.0]hexane derivatives useful in therapy
|
JP4507026B2
(ja)
|
1999-04-06 |
2010-07-21 |
東洋紡績株式会社 |
ハレーション防止用組成物およびそれを用いた感光性樹脂積層体
|
BR0010702A
(pt)
|
1999-04-30 |
2002-02-13 |
Slil Biomedical Corp |
Novas quinonas como terapias de doenças
|
JP2003513078A
(ja)
|
1999-11-05 |
2003-04-08 |
アバンテイス・フアルマ・エス・アー |
オリゴベンズイミダゾール誘導体及びdna形質転換剤としてのそれらの使用
|
NZ519209A
(en)
|
1999-12-20 |
2003-11-28 |
Univ Georgia State Res Found |
Diamidine compounds useful as DNA minor groove binders
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
GB0011092D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (III)
|
CA2433070A1
(en)
|
2001-01-13 |
2002-07-18 |
The University Of North Carolina At Chapel Hill |
Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
|
US6709929B2
(en)
|
2001-06-25 |
2004-03-23 |
North Carolina State University |
Methods of forming nano-scale electronic and optoelectronic devices using non-photolithographically defined nano-channel templates
|
WO2003017994A1
(en)
|
2001-08-31 |
2003-03-06 |
Neurochem (International) Limited |
Amidine derivatives for treating amyloidosis
|
WO2003045929A1
(fr)
|
2001-11-26 |
2003-06-05 |
Takeda Chemical Industries, Ltd. |
Derive bicyclique, procede de production de ce derive et utilisation correspondante
|
WO2003048140A1
(fr)
|
2001-12-03 |
2003-06-12 |
Japan Tobacco Inc. |
Compose azole et utilisation medicinale de celui-ci
|
JP2004024114A
(ja)
|
2002-06-26 |
2004-01-29 |
Shigeori Takenaka |
電気化学的二本鎖dna検出試薬としての新規インターカレータ
|
AU2003259068B2
(en)
|
2002-08-09 |
2009-07-02 |
Astrazeneca Ab |
"1,2,4"oxadiazoles as modulators of metabotropic glutamate receptor-5
|
EP1539754A4
(en)
|
2002-08-23 |
2009-02-25 |
Novartis Vaccines & Diagnostic |
BENZIMIDAZOLE QUINOLINONES AND USES THEREOF
|
US20050256157A1
(en)
|
2002-08-23 |
2005-11-17 |
Chiron Corporation |
Combination therapy with CHK1 inhibitors
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
EP1651631A1
(en)
|
2003-08-01 |
2006-05-03 |
Genelabs Technologies, Inc. |
Bicyclic imidazol derivatives against flaviviridae
|
JP2007521237A
(ja)
|
2003-09-05 |
2007-08-02 |
ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
微生物感染症処置用の新規アミジン化合物
|
WO2005046589A2
(en)
|
2003-11-07 |
2005-05-26 |
Chiron Corporation |
Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
|
CA2555409A1
(en)
|
2004-02-19 |
2005-09-01 |
Banyu Pharmaceutical Co., Ltd. |
Novel sulfone amide derivative
|
CA2599304C
(en)
|
2004-02-27 |
2014-07-08 |
Peter Maccallum Cancer Institute |
Cell targeting conjugates
|
WO2005086754A2
(en)
|
2004-03-08 |
2005-09-22 |
Georgia State University Research Foundation, Inc. |
Dicationic compounds for activity against trichomonas vaginalis
|
CA2579889A1
(en)
|
2004-09-09 |
2006-03-16 |
Astellas Pharma Inc. |
Thiazole derivatives having vap-1 inhibitory activity
|
EP1797072A4
(en)
|
2004-09-17 |
2009-09-09 |
Exelixis Inc |
PYRAZOLKINASE MODULATORS AND USE METHOD
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
JP5390186B2
(ja)
|
2005-08-12 |
2014-01-15 |
ユナイテッド ステイツ ガバメント アズ レプリゼンティッド バイ ザ セクレタリー オブ ザ ユナイテッド ステイツ アーミー アンド ザ ユーエス アーミー メディカル リサーチ アンド マティリ |
広い抗菌スペクトルを有する抗菌性化合物
|
WO2007027594A1
(en)
|
2005-08-29 |
2007-03-08 |
Vertex Pharmaceuticals Incorporated |
3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
|
JP5301999B2
(ja)
|
2005-10-31 |
2013-09-25 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Cetp阻害薬
|
AU2007335185B2
(en)
|
2006-12-21 |
2013-06-27 |
Peter Maccallum Cancer Institute |
Radioprotector compounds and related methods
|
CA2681813A1
(en)
|
2007-03-27 |
2009-01-08 |
Paratek Pharmaceuticals, Inc. |
Transcription factor modulating compounds and methods of use thereof
|
GB0707934D0
(en)
|
2007-04-24 |
2007-05-30 |
Glaxo Group Ltd |
Chemical compounds
|
US7662526B2
(en)
|
2007-05-04 |
2010-02-16 |
Xerox Corporation |
Photoconductors
|
JP5514716B2
(ja)
|
2007-05-11 |
2014-06-04 |
コリア・リサーチ・インスティテュート・オブ・ケミカル・テクノロジー |
アリールピペリジン置換基を有するイミダゾール誘導体、その製造方法及びこれを含む医薬組成物
|
JP2009005594A
(ja)
|
2007-06-26 |
2009-01-15 |
Kyoto Univ |
遺伝子診断機能性蛍光色素の製造方法
|
CA2708281A1
(en)
|
2007-12-11 |
2009-08-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
WO2009087379A2
(en)
|
2008-01-09 |
2009-07-16 |
Amura Therapeutics Limited |
Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases
|
CN104163816A
(zh)
|
2008-12-03 |
2014-11-26 |
普雷西迪奥制药公司 |
Hcv ns5a的抑制剂
|
CA2745119A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
EP2367824B1
(en)
|
2008-12-23 |
2016-03-23 |
AbbVie Inc. |
Anti-viral derivatives of pyrimidine
|
US20120040977A1
(en)
|
2009-02-23 |
2012-02-16 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
KR101219487B1
(ko)
|
2009-03-03 |
2013-01-15 |
덕산하이메탈(주) |
비스벤조이미다졸 화합물 및 이를 이용한 유기전기소자, 그단말
|
ES2787599T3
(es)
|
2009-05-13 |
2020-10-16 |
Univ Virginia Patent Foundation |
Inhibidores de leucemia inv(16)
|
EP2337781B1
(en)
|
2009-06-11 |
2014-07-23 |
AbbVie Bahamas Ltd. |
Anti-viral compounds to treat hcv infection
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
JPWO2011007756A1
(ja)
|
2009-07-13 |
2012-12-27 |
武田薬品工業株式会社 |
複素環化合物及びその用途
|
US9072761B2
(en)
|
2009-08-14 |
2015-07-07 |
Clemson University Research Foundation (Curf) |
Methods and compositions related to viral inhibition
|
US9156818B2
(en)
|
2009-09-11 |
2015-10-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US20110152246A1
(en)
|
2009-12-18 |
2011-06-23 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
US8933110B2
(en)
|
2010-01-25 |
2015-01-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2011099832A2
(en)
|
2010-02-12 |
2011-08-18 |
Crystalgenomics, Inc. |
Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
|
WO2011119858A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
CA2794181A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
AU2011232331A1
(en)
|
2010-03-24 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of Flavivirus infections
|
WO2011151618A2
(en)
|
2010-06-01 |
2011-12-08 |
Summit Corporation Plc |
Compounds for the treatment of clostridium difficile-associated disease
|
JP5695749B2
(ja)
|
2010-09-28 |
2015-04-08 |
デーウン ファーマシューティカル カンパニー リミテッド |
ベンゾイミダゾール誘導体の新規な製造方法
|
WO2012044567A2
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Imidazole derivatives
|
JP5906253B2
(ja)
|
2010-12-16 |
2016-04-20 |
アッヴィ・インコーポレイテッド |
抗ウイルス性化合物
|
WO2012123298A1
(en)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
EP2694060A4
(en)
|
2011-04-01 |
2014-09-10 |
Univ Utah Res Found |
SUBSTITUTED 3- (1H-BENZO [D] IMIDAZOL-2-YL) -1H-INDAZOLE ANALOGUES AS INHIBITORS OF PDK1 KINASE
|
US8785436B2
(en)
|
2011-05-16 |
2014-07-22 |
Hoffmann-La Roche Inc. |
1,3-oxazines as BACE 1 and/or BACE2 inhibitors
|
US9353115B2
(en)
|
2011-06-01 |
2016-05-31 |
Janus Biotherapeutics, Inc. |
Immune system modulators
|
CN103874702B
(zh)
|
2011-07-15 |
2015-12-09 |
杨森制药公司 |
作为γ分泌酶调节剂的经取代的吲哚衍生物
|
US9464064B2
(en)
|
2011-09-07 |
2016-10-11 |
University Of Kansas |
HCV helicase inhibitors and methods of use thereof
|
WO2013049567A1
(en)
|
2011-09-29 |
2013-04-04 |
The Broad Institute, Inc. |
Compounds for the treatment of mycobacterial infections
|
EP2765860B1
(en)
|
2011-10-13 |
2016-08-17 |
Merck Sharp & Dohme Corp. |
Mineralocorticoid receptor antagonists
|
JP2014534206A
(ja)
|
2011-10-17 |
2014-12-18 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
C型肝炎ウイルス阻害剤
|
WO2013074387A1
(en)
|
2011-11-14 |
2013-05-23 |
Merck Sharp & Dohme Corp. |
Imidazole derivatives
|
EP3290413B9
(en)
|
2011-12-21 |
2020-04-29 |
ONO Pharmaceutical Co., Ltd. |
Pyridinone and pyrimidinone derivatives as factor xia inhibitors
|
CA2861020C
(en)
|
2012-02-02 |
2018-07-17 |
Actelion Pharmaceuticals Ltd |
4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives and their use as cxcr3 receptor modulators
|
EP2647628A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Substituted tricyclic compounds with activity towards ep1 receptors
|
TWI610916B
(zh)
|
2012-08-03 |
2018-01-11 |
廣東東陽光藥業有限公司 |
作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
|
TW201412709A
(zh)
|
2012-09-28 |
2014-04-01 |
Sunshine Lake Pharma Co Ltd |
作為丙型肝炎抑制劑的螺環化合物及其在藥物中的應用
|
US9047780B2
(en)
|
2012-11-16 |
2015-06-02 |
Robert Bosch Gmbh |
Collision mitigation systems and methods using driver attentiveness
|
WO2014081280A2
(en)
|
2012-11-21 |
2014-05-30 |
Lim Pooi Nguon |
Information medium and a method of producing the same
|
WO2014082381A1
(en)
|
2012-11-29 |
2014-06-05 |
Sunshine Lake Pharma Co., Ltd. |
Spiro ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
|
CN103880823B
(zh)
|
2012-12-21 |
2017-12-05 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的螺环化合物及其在药物中的应用
|
RU2015138924A
(ru)
|
2013-02-13 |
2017-03-20 |
Сумитомо Кемикал Компани, Лимитед |
Композиция для борьбы с вредителями и ее применение
|
WO2014134240A1
(en)
|
2013-02-28 |
2014-09-04 |
Signal Pharmaceuticals, Llc |
Treatment of cancer with tor kinase inhibitors
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
TWI527811B
(zh)
*
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
CN111116563B
(zh)
|
2013-06-06 |
2023-07-04 |
上海爱博医药科技有限公司 |
抑制丙肝病毒的化合物、药物组合物及其应用
|
WO2015004534A2
(en)
*
|
2013-06-21 |
2015-01-15 |
Zenith Epigenetics Corp. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
AU2014290206B2
(en)
|
2013-07-15 |
2018-03-29 |
The Scripps Research Institute |
Specific targeting of RNA expanded repeat sequences
|
US9795687B2
(en)
|
2013-08-29 |
2017-10-24 |
The Scripps Research Institute |
Modularly assembled small molecules for the treatment of myotonic dystrophy type 1
|
US9920014B2
(en)
|
2013-09-19 |
2018-03-20 |
The Florida International University Board Of Trustees |
Selective inhibition of bacterial topoisomerase I
|
MX2016004570A
(es)
|
2013-10-11 |
2016-09-08 |
Genentech Inc |
Uso de inhibidores del bromodominio de cbp/ep300 para la inmunoterapia del cáncer.
|
JP6217317B2
(ja)
|
2013-10-30 |
2017-10-25 |
株式会社リコー |
色素増感太陽電池
|
CN104610272B
(zh)
|
2013-11-05 |
2017-03-29 |
上海唐润医药科技有限公司 |
环状黄酮或异黄酮类化合物及其用途
|
CN103728294B
(zh)
|
2013-12-17 |
2016-05-11 |
中国科学院化学研究所 |
二苯并咪唑联咔唑类化合物在用于特异性结合核酸g-四链体结构及在抗肿瘤药物中的应用
|
CN104803989B
(zh)
|
2014-01-23 |
2017-12-22 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的桥环化合物及其在药物中的应用
|
CN103952009B
(zh)
|
2014-05-08 |
2015-12-30 |
中国工程物理研究院化工材料研究所 |
一种近红外宽光谱金属配合物染料及其制备方法
|
PL408251A1
(pl)
|
2014-05-19 |
2015-11-23 |
Celon Pharma Spółka Z Ograniczoną Odpowiedzialnością |
Skondensowane pochodne triazolu jako inhibitory fosfodiesterazy 10A
|
CN104030988B
(zh)
|
2014-06-25 |
2016-07-06 |
上海道亦化工科技有限公司 |
一种基于苯并咪唑的电子传输化合物
|
CN104193738B
(zh)
|
2014-08-21 |
2016-05-18 |
上海道亦化工科技有限公司 |
一种基于苯并咪唑的电子传输化合物
|
JP2017529358A
(ja)
|
2014-09-19 |
2017-10-05 |
ジェネンテック, インコーポレイテッド |
がんの処置のためのcbp/ep300阻害剤およびbet阻害剤の使用
|
CA2966450A1
(en)
|
2014-12-17 |
2016-06-23 |
Olesya KHARENKO |
Inhibitors of bromodomains
|
CA2966452A1
(en)
|
2014-12-17 |
2016-06-23 |
Samuel David Brown |
Substituted bicyclic compounds as bromodomain inhibitors
|
CN104710410B
(zh)
|
2015-01-23 |
2017-10-10 |
固安鼎材科技有限公司 |
一种联苯并咪唑衍生物、其制备方法及其应用
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|